Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic
- PMID: 18247079
- DOI: 10.1007/s10067-008-0845-9
Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic
Abstract
The aim of the study was to evaluate factors that influence health status and work disability in patients with ankylosing spondylitis (AS) in the Czech Republic. Data were collected in a retrospective fashion directly from patients with AS using mailed questionnaires containing questions regarding sociodemographic characteristics of patients, the course of their disease, therapy, rehabilitation, quality of life, and ability to work. HAQ-DI (Health Assessment Questionnaire-Disability Index) and BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) were also included in the questionnaires; 1,008 questionnaires were suitable for further statistical analysis. The average age +/- SD of patients was 50.2 +/- 10.7 years, the average symptom duration was 23.0 +/- 11.6 years. Mean time from first symptoms to diagnosis was 9.1 years. Full disability had been awarded to 303 patients (30%) at some point of their disease. Twenty seven percent of patients reported receiving full disability pension for 10 or more years. Four hundred fifty six subjects (45%) were currently or had been previously receiving partial disability pension. Receiving disability pension was more frequent among men (64%) compared to women (56%) (P = 0.012), despite the fact that women had higher BASDAI (P < 0.001) and HAQ-DI (P = 0.004) scores. Patients with a family history of AS had higher BASDAI and HAQ-DI scores (P = 0.001 and P = 0.008, respectively) compared to patients without a family history of AS. BASDAI and HAQ-DI scores correlated with age and duration of illness, younger patients and those with shorter disease duration had lower values. Fifty eight percent of patients reported a BASDAI score > or =4 (current cutoff value for initiation of biological therapy), but only 1% of patients were treated by anti TNF alpha agents within the last year. Seven hundred ninety one patients underwent spa treatment in the previous year; 96% of them experienced improvement of their health condition.
Similar articles
-
Association of health care utilization and costs with patient-reported outcomes in patients with ankylosing spondylitis.J Manag Care Spec Pharm. 2022 Sep;28(9):1008-1020. doi: 10.18553/jmcp.2022.28.9.1008. J Manag Care Spec Pharm. 2022. PMID: 36001102 Free PMC article.
-
Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry.Expert Opin Biol Ther. 2020 Feb;20(2):183-192. doi: 10.1080/14712598.2020.1694900. Epub 2019 Nov 25. Expert Opin Biol Ther. 2020. PMID: 31736377
-
Assessment of fatigue in Moroccan patients with ankylosing spondylitis.Clin Rheumatol. 2010 Nov;29(11):1295-9. doi: 10.1007/s10067-010-1558-4. Epub 2010 Aug 28. Clin Rheumatol. 2010. PMID: 20803045
-
Relationship of work disability between the disease activity, depression and quality of life in patients with ankylosing spondylitis.J Back Musculoskelet Rehabil. 2018;31(3):499-505. doi: 10.3233/BMR-169657. J Back Musculoskelet Rehabil. 2018. PMID: 29504521
-
Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S).Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S47-58. doi: 10.1002/acr.20575. Arthritis Care Res (Hoboken). 2011. PMID: 22588768 Review. No abstract available.
Cited by
-
Home-based exercise therapy in ankylosing spondylitis: short-term prospective study in patients receiving tumor necrosis factor alpha inhibitors.Rheumatol Int. 2013 Jan;33(1):71-7. doi: 10.1007/s00296-011-2344-6. Epub 2012 Jan 5. Rheumatol Int. 2013. PMID: 22218641
-
Elevated Tenascin-C Serum Levels in Patients With Axial Spondyloarthritis.Physiol Res. 2020 Aug 31;69(4):653-660. doi: 10.33549/physiolres.934414. Epub 2020 Jun 25. Physiol Res. 2020. PMID: 32584134 Free PMC article.
-
Diagnostic delay in axial spondyloarthritis: a systematic review.Clin Rheumatol. 2022 Jul;41(7):1939-1950. doi: 10.1007/s10067-022-06100-7. Epub 2022 Feb 19. Clin Rheumatol. 2022. PMID: 35182270 Free PMC article.
-
Fifteen-year trends of long-term disability and sick leaves in ankylosing spondylitis.Clin Rheumatol. 2011 Mar;30(3):361-7. doi: 10.1007/s10067-010-1669-y. Epub 2011 Jan 6. Clin Rheumatol. 2011. PMID: 21210289
-
Psychosocial burden of axial spondyloarthritis and impact of different disease domains: a systematic literature review.Rheumatol Adv Pract. 2025 May 26;9(3):rkaf063. doi: 10.1093/rap/rkaf063. eCollection 2025. Rheumatol Adv Pract. 2025. PMID: 40584930 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials